Wilson disease is a rare inherited disorder of copper metabolism caused by pathogenic variants in the ATP7B gene. The condition prevents the body from properly transporting and eliminating excess copper, causing copper to accumulate primarily in the liver and, in some patients, the brain, eyes and other organs. Wilson disease can cause liver disease, neurological or movement disorders, psychiatric symptoms and other systemic complications. It is inherited in an autosomal recessive pattern.
Timely diagnosis and lifelong treatment are important because progressive copper accumulation can cause irreversible liver and neurological damage. Early treatment can reduce copper accumulation, prevent further organ injury and help control existing symptoms. Individuals with severe liver failure or disease that does not respond adequately to medical treatment may require liver transplantation.
Causes
Risk Factors
Liver Transplantation : Liver transplantation may be considered for patients with acute liver failure, severe decompensated liver disease or inadequate response to appropriate medical treatment.
Cost Start From 45000Explore Options
Copper-Lowering Medical Treatment: Lifelong treatment helps remove excess copper from the body or reduce its absorption, preventing further accumulation and organ damage.
Long-Term Monitoring: Regular assessment of liver function, copper levels, treatment response and possible adverse effects helps guide ongoing care and identify complications.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support Wilson Disease patients in Turkey. These services include:









Istanbul, Turkey
Medicana Camlica Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

Istanbul, Turkey
Memorial Sisli Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

Istanbul, Turkey
The first green hospital in Turkey, Istanbul Florence Nightingale Hospital, was inaugurated in 2013. Group The Florence Nightingale hospitals are the first Turkish hospitals to be granted Joint Commission International (JCI) accreditation, and they continue to be associated and work with esteemed healthcare organizations.
The Florence Nightingale Group treats 250,000 outpatients and 70,000 inpatients annually, demonstrating its excellence. The hospitals have a capacity of 804 inpatient beds, 141 ICU beds, and 40 operating rooms, and perform 20,000+ procedures annually, of which 1,000 are cardiac operations for children and 2,000 are for adults. For conducting difficult orthopedic, general surgery, minimally invasive, and other heart treatments, the facility stands out. All operating rooms can be interconnected by audio-visual to a 300-person conference room and global hubs, enabling interactive medical teaching and scientific activity.
Interpreter and translator services for languages such as Turkish, Azerbaijani, Bulgarian, Arabic, English, Persian, Serbian, Russian, Albanian, Macedonian, German, Bosnian, and Romanian are available.
The hospital has specialized departments such as Cardiology and Cardiac Surgery, IVF and Infertility, Nephrology, Oncology and Oncosurgery, Spine Surgery, Neurology and Neurosurgery, Orthopedics, Gynecology, and Obesity or Bariatric Surgery. With an extensively qualified and experienced team of advisors and interpreters, Florence Nightingale Istanbul is committed to providing one-stop service from beginning to end, 24 hours a day, 7 days a week.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome

Hematologist
9 Years of Experience
Dr. Akash Khandelwal is a distinguished Hematologist, Hemato-oncologist, and Bone Marrow Transplant (BMT) Physician with extensive training from the prestigious AIIMS New Delhi. His expertise encompasses a wide range of specialized techniques in bone marrow transplantation, including autologous and allogeneic transplants such as matched sibling donors, matched unrelated donors (MUD), and haploidentical donor transplants. Dr. Khandelwal has personally supervised and conducted over 100 bone marrow transplants. View More
Last Reviewed - January 2026